Press Release: Kinaxis Inc. Reports Record First Quarter 2026 Results

Dow Jones
May 07
   --  Q1 SaaS revenue grows 21% versus 16% a year ago 
 
   --  Record new business for a Q1 drives ARR2 growth of 20% versus 14% a 
      year ago 
 
   --  Delivered record Q1 profit and adjusted EBITDA1, adjusted EBITDA 
      margin1 up to 32% 
OTTAWA, Ontario--(BUSINESS WIRE)--May 06, 2026-- 

Kinaxis$(R)$ (TSX:KXS), a global leader in end-to-end supply chain planning and orchestration, reported record results for its first quarter ended March 31, 2026. All amounts are in U.S. dollars. All figures are prepared in accordance with IFRS Accounting Standards (IFRS) unless otherwise indicated.

"We continue to have tremendous success winning the largest new customer opportunities and expanding with existing customers, which together is driving record levels of bookings and ARR growth. We were thrilled with continued traction in scaling up our business through market leading innovations and further customer success earned alongside our partner ecosystem," said Razat Gaurav, chief executive officer at Kinaxis. "We're seeing good early-stage demand for our Maestro Agents, with new paying customers in Q1. At the same time, we experienced strong demand for our market leading, end-to-end AI-driven demand and supply planning capabilities, which use a combination of advanced optimization, heuristics and machine learning models. Agentic and Generative AI are tremendous complements to deep mathematical techniques, and when leveraging the latest data architectures, all these technologies combined will be critical to helping organizations manage their supply chains amidst the unprecedented levels of volatility in demand and supply."

Q1 2026 Highlights

 
$ USD thousands, except as otherwise indicated      Q1 2026   Q1 2025   Change 
------------------------------------------------  ---------  --------  ------- 
Total Revenue                                       165,568   132,788      25% 
------------------------------------------------  ---------  --------  ------- 
                                            SaaS    102,885    84,882      21% 
                      Subscription term licenses     19,052     9,027     111% 
                           Professional services     38,720    33,340      16% 
                         Maintenance and support      4,911     5,539    (11)% 
------------------------------------------------  ---------  --------  ------- 
Gross profit                                        114,016    86,539      32% 
Margin                                                  69%       65% 
------------------------------------------------  ---------  --------  ------- 
Profit                                               29,420    15,913      85% 
Per diluted share                                     $1.04     $0.55 
------------------------------------------------  ---------  --------  ------- 
Adjusted EBITDA(1)                                   53,603    33,143      62% 
Margin                                                  32%       25% 
------------------------------------------------  ---------  --------  ------- 
Cash flows from operating activities                 59,082    31,647      87% 
------------------------------------------------  ---------  --------  ------- 
 
(1) "Adjusted EBITDA" is a non-IFRS measure that is not a recognized, defined 
or standardized measure under IFRS. This measure as well as any other non-IFRS 
financial measures reported by Kinaxis are defined in the "Non-IFRS Measures" 
section of this news release. 
 

Key Performance Indicators

The company's Annual Recurring Revenue(2) $(ARR)$, which includes subscription amounts related to both SaaS and on-premise contracts, rose 20% to $447 million at the end of the quarter.

 
$USD millions                                Q1 2026       Q1 2025      Change 
--------------------------------------  ------------  ------------  ---------- 
Annual recurring revenue(2)                      447           372         20% 
--------------------------------------  ------------  ------------  ---------- 
 
(2) Annual Recurring Revenue (ARR) is the total annualized value of recurring 
subscription amounts (ultimately recognized as SaaS, Subscription term 
licenses and Maintenance and support revenue) of all subscription contracts at 
a point in time. Annualized subscription amounts are determined solely by 
reference to the underlying contracts, normalizing for the varying revenue 
recognition treatments under IFRS 15 for cloud-based versus on-premise 
subscription amounts. It excludes one-time fees, such as for non-recurring 
professional services, and assumes that customers will renew the contractual 
commitments on a periodic basis as those commitments come up for renewal, 
unless such renewal is known to be unlikely. We believe that this measure 
provides a more current indication of our performance in the growth of our 
subscription business than other metrics. 
 

The nature of the company's long-term contracts provides visibility into future, contracted revenue. The following table presents revenue expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at March 31, 2026.

 
 
 $USD millions                2026   2027   2028 and later   Total 
---------------------------  -----  -----  ---------------  ------ 
SaaS                         295.7  306.2            303.5   905.4 
---------------------------  -----  -----  ---------------  ------ 
Maintenance and support       11.4   13.8             12.3    37.5 
---------------------------  -----  -----  ---------------  ------ 
Subscription term licenses     2.2    3.3              0.3     5.8 
---------------------------  -----  -----  ---------------  ------ 
                      Total  309.3  323.3            316.1   948.7 
---------------------------  -----  -----  ---------------  ------ 
 

Financial Guidance

Kinaxis is reiterating its fiscal 2026 financial guidance, as follows.

 
                            FY 2026 Guidance 
--------------------------  ---------------- 
Total revenue               $620-635 million 
--------------------------  ---------------- 
SaaS revenue growth            17-19% growth 
--------------------------  ---------------- 
Adjusted EBITDA(1) margin             25-26% 
--------------------------  ---------------- 
 

"I couldn't be more excited than to complete my time at Kinaxis with such a stellar quarter. Despite our outperformance, we are maintaining all aspects of annual guidance, which we provided only 60 days ago. It is early in the year and we will gather more information and review assumptions next quarter. In any case, Kinaxis exits the first quarter with even more confidence in our 2026 targets," said Blaine Fitzgerald, chief financial officer at Kinaxis.

Guidance in this press release is provided to enhance visibility into Kinaxis' expectations for financial targets for the periods indicated. Please refer to the section regarding forward-looking statements that forms an integral part of this release. This press release along with the financial statements and MD&A for the quarter ended March 31, 2026 are available on Kinaxis' website and on SEDAR+ at www.sedarplus.ca.

Conference Call

Kinaxis will host a conference call tomorrow, May 7, 2026, to discuss these results. Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, will host the call starting at 8:30 a.m. Eastern Time. A question and answer session will follow management's presentation.

 
DATE:     Thursday, May 7, 2026 
TIME:     8:30 a.m. Eastern Time 
WEBCAST   https://events.q4inc.com/attendee/986528748 (available for three 
          months) 
 

About Kinaxis Inc.

Kinaxis is a global leader in modern supply chain planning and orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro$(TM)$, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain -- from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today's volatility and disruption. For more news and information, please visit kinaxis.com or follow us on LinkedIn.

Non-IFRS Measures

This press release makes reference to Adjusted Profit and Adjusted EBITDA, which are non-IFRS financial measures, as well as Adjusted EBITDA margin which expresses Adjusted EBITDA as a percentage of revenue. Adjusted Profit, Adjusted EBITDA and Adjusted EBITDA margin are not recognized, defined or standardized measures under IFRS. We use these measures to provide investors with supplemental information on our operating performance and to highlight trends in our core business that may not otherwise be apparent when relying solely on IFRS financial measures. We believe that securities analysts, investors and other interested parties frequently use non-IFRS measures in the evaluation of issuers. Providing these non-IFRS measures provides useful information because they portray the financial results of the Company before certain expenses that do not impact the ongoing operating decisions taken by management. Management also uses non-IFRS measures in order to facilitate operating performance comparisons from period to period, prepare annual operating budgets and assess our ability to meet our capital expenditure and working capital requirements, and to determine components of employee compensation.

Adjusted Profit represents profit adjusted to exclude our equity compensation plans. Adjusted EBITDA represents profit adjusted to exclude our equity compensation plans, income tax expense, depreciation and amortization, foreign exchange loss (gain) and net finance (income) expense. Adjusted EBITDA margin expresses Adjusted EBITDA as a percentage of revenue. Our definitions of Adjusted Profit, Adjusted EBITDA and Adjusted EBITDA margin will likely differ from those used by other companies (including our peers) and therefore comparability may be limited. Non-IFRS measures should not be considered a substitute for or in isolation from measures prepared in accordance with IFRS. Investors are encouraged to review our financial statements and disclosures in their entirety and are cautioned not to put undue reliance on non-IFRS measures and view them in conjunction with the most comparable IFRS financial measures. Kinaxis has reconciled Adjusted Profit and Adjusted EBITDA to the most comparable IFRS financial measure as follows:

 
                                             Three months ended March 31, 
                                            ------------------------------ 
                                                 2026            2025 
                                            --------------  -------------- 
                                                (In thousands of USD) 
 Profit                                             29,420          15,913 
 Share-based compensation                            8,620           9,347 
                                            --------------  -------------- 
 Adjusted profit                                    38,040          25,260 
                                            ==============  ============== 
 Income tax expense                                 13,915           5,740 
 Depreciation and amortization                       4,676           5,423 
 Foreign exchange (gain)                             (494)           (914) 
 Net finance income                                (2,534)         (2,366) 
                                            --------------  -------------- 
                                                    15,563           7,883 
                                            --------------  -------------- 
 Adjusted EBITDA                                    53,603          33,143 
                                            ==============  ============== 
 Adjusted EBITDA as a percentage of 
  revenue                                              32%             25% 
 

Forward-Looking Statements

Certain statements in this release constitute forward-looking statements, future-oriented financial information and financial outlook within the meaning of applicable securities laws. Forward-looking statements, future-oriented financial information and financial outlook include statements as to our expectations for:

   --  growth of annual total revenue, annual SaaS revenue growth, and our 
      expectations for Adjusted EBITDA margin achievement, in each case looking 
      forward for our fiscal year ending December 31, 2026; 
 
   --  SaaS growth and increased profitability in years beyond 2026; and 
 
   --  contracted revenue in future periods, including 2026, 2027 and 2028 and 
      later. 

This release also includes forward-looking statements as to Kinaxis' growth opportunities and the potential benefits of, and markets and demand for, Kinaxis' products and services. These statements are subject to certain assumptions, risks and uncertainties, including our view of the relative position of Kinaxis' products and services compared to competitive offerings in the industry.

In particular, our guidance for 2026 annual total revenue, annual SaaS revenue growth and annual Adjusted EBITDA margin, as well as our comments on our expectations for SaaS growth and increased profitability in years beyond 2026, are subject to certain assumptions and associated risks including:

   --  our ability to win business from new customers and expand business from 
      existing customers; 
 
   --  the timing of new customer wins and expansion decisions by our existing 
      customers; 
 
   --  maintaining our customer retention levels, and specifically, that 
      customers will renew contractual commitments on a periodic basis as those 
      commitments come up for renewal, at rates consistent with our historic 
      experience; 
 
   --  anticipated trends, standards and challenges in our business and the 
      markets we operate in; 
 
   --  fluctuations in the value of foreign currencies relative to the U.S. 
      Dollar; and 
 
   --  with respect to Adjusted EBITDA and profitability, our ability to 
      contain expense levels while expanding our business. 

Our guidance and commentary for achievement of contracted revenue in future periods, including in 2026, 2027 and 2028 and later, is based on assumptions and associated risks including:

   --  our ability to satisfy material unperformed obligations under our 
      long-term contracts; and 
 
   --  the continued financial capacity and creditworthiness of our customers 
      under long-term contracts. 

These and other assumptions, risks and uncertainties may cause Kinaxis' actual results, performance, achievements and developments to differ materially from the results, performance, achievements or developments expressed or implied by forward-looking statements, future-oriented financial information or financial outlook. Material risks and uncertainties relating to our business are described under the headings "Forward-Looking Statements" and "Risks and Uncertainties" in our annual MD&A dated March 4, 2026, and under the heading "Risk Factors" in our Annual Information Form dated March 4, 2026, which are available at www.sedarplus.ca. Readers are cautioned that the assumptions used in the preparation of forward-looking statements, future-oriented financial information and financial outlook, although considered reasonable at the time of preparation, may prove to be imprecise or inaccurate and, as such, undue reliance should not be placed on such information. Our actual results, performance and achievements could differ materially from those expressed in, or implied by, such forward-looking statements, future-oriented financial information or financial outlook. Forward-looking statements, future-oriented financial information and financial outlook are provided to help readers understand management's expectations as at the date of this release and may not be suitable for other purposes. Readers are cautioned not to place undue reliance on forward-looking statements. Kinaxis assumes no obligation to update or revise any forward-looking statements, future-oriented financial information or financial outlook whether as a result of new information, future events or otherwise, except as expressly required by law.

SOURCE: Kinaxis Inc.

 
 
Kinaxis Inc. 
 Condensed Consolidated Interim Statements of Financial Position 
 (Expressed in thousands of USD) 
 
                                             March 31,     December 31, 
                                                  2026             2025 
-----------------------------------------  -----------   -------------- 
 
Assets 
Current assets: 
      Cash and cash equivalents             $  230,129    $     149,614 
      Short-term investments                    97,499          175,095 
      Trade and other receivables              167,465          165,781 
      Prepaid expenses                          28,082           15,743 
-----------------------------------------      -------       ---------- 
                                               523,175          506,233 
Non-current assets: 
      Unbilled receivables                       2,637            1,596 
      Other receivables                          1,014            1,047 
      Prepaid expenses                           3,181            1,558 
      Deferred tax assets                       15,703           18,225 
      Contract acquisition costs                40,326           37,038 
      Property and equipment                    27,048           28,526 
      Right-of-use assets                       43,363           43,090 
      Intangible assets                          9,760           10,804 
      Goodwill                                  75,810           76,597 
-----------------------------------------      -------       ---------- 
                                               218,842          218,481 
 
                                            $  742,017    $     724,714 
-----------------------------------------      -------       ---------- 
 
Liabilities and Shareholders' Equity 
Current liabilities: 
      Trade payables and accrued 
       liabilities                          $  109,021    $      90,040 
      Deferred revenue                         189,585          161,060 
      Lease obligations                          6,119            5,938 
-----------------------------------------      -------       ---------- 
                                               304,725          257,038 
Non-current liabilities: 
      Lease obligations                         41,543           42,065 
      Deferred tax liabilities                   3,557            4,042 
-----------------------------------------      -------       ---------- 
                                                45,100           46,107 
Shareholders' equity: 
      Share capital                            386,780          363,246 
      Accumulated other comprehensive 
       loss                                     (2,791)            (223) 
      Retained earnings                          8,203           58,546 
-----------------------------------------      -------       ---------- 
                                               392,192          421,569 
 
                                            $  742,017    $     724,714 
-----------------------------------------      -------       ---------- 
 
 
 
Kinaxis Inc. 
 Condensed Consolidated Interim Statements of Comprehensive Income 
 (Expressed in thousands of USD, except share and per share data) 
 
                                            Three months ended March 31, 
                                                      2026            2025 
----------------------------------------      ------------    ------------ 
Revenue                                    $       165,568   $     132,788 
 
Cost of revenue                                     51,552          46,249 
 
Gross profit                                       114,016          86,539 
 
Operating expenses: 
      Selling and marketing                         29,563          28,689 
      Research and development                      27,460          22,668 
      General and administrative                    16,687          16,866 
----------------------------------------      ------------    ------------ 
                                                    73,710          68,223 
 
                                                    40,306          18,316 
 
Other income: 
      Foreign exchange gain                            494             914 
      Net finance and other income                   2,535           2,423 
----------------------------------------      ------------    ------------ 
                                                     3,029           3,337 
 
Profit before income taxes                          43,335          21,653 
 
Income tax expense                                  13,915           5,740 
 
Profit                                              29,420          15,913 
 
Other comprehensive income (loss): 
Items that are or may be reclassified 
subsequently to profit 
      Foreign currency translation 
       differences - foreign operations             (2,147)          1,077 
      Change in valuation of cash flow 
       hedges                                         (421)            577 
----------------------------------------      ------------    ------------ 
                                                    (2,568)          1,654 
 
Total comprehensive income                 $        26,852   $      17,567 
----------------------------------------      ------------    ------------ 
 
Basic earnings per share                   $          1.06   $        0.57 
Weighted average number of basic Common 
 Shares                                         27,717,242      28,094,465 
Diluted earnings per share                 $          1.04   $        0.55 
Weighted average number of diluted 
 Common Shares                                  28,313,923      28,788,191 
----------------------------------------      ------------    ------------ 
 
 
 
Kinaxis Inc. 
 Condensed Consolidated Interim Statements of Changes in Shareholders' Equity 
 (Expressed in thousands of USD) 
 
                                          Accumulated other comprehensive income 
                                                          (loss) 
                                          --------------------------------------- 
                                                               Currency 
                    Share    Contributed     Cash flow      translation             Retained        Total 
                  capital        surplus        hedges      adjustments     Total   earnings       equity 
--------------  ---------  -------------  ------------  ---------------  --------  ---------  ----------- 
 
Balance, 
 December 31, 
 2024           $329,312    $    12,078   $(1,203)       $   (2,644)     $(3,847)  $ 57,968   $395,511 
 
Profit                --             --        --                --           --     15,913     15,913 
Other 
 comprehensive 
 income               --             --       577             1,077        1,654         --      1,654 
--------------   -------       --------    ------  ---      -------       ------    -------    ------- 
Total 
 comprehensive 
 income               --             --       577             1,077        1,654     15,913     17,567 
 
Share options 
 exercised         7,625         (1,805)       --                --           --         --      5,820 
Restricted 
 share units 
 vested           12,828        (12,828)       --                --           --         --         -- 
Performance 
 share units 
 vested            3,262         (3,262)       --                --           --         --         -- 
Share-based 
 payments             --          8,527        --                --           --         --      8,527 
Shares 
 repurchased        (974)        (2,710)       --                --           --    (12,957)   (16,641) 
--------------   -------       --------    ------  ---      -------       ------    -------    ------- 
Total 
 shareholder 
 transactions     22,741        (12,078)       --                --           --    (12,957)    (2,294) 
 
Balance, March 
 31, 2025       $352,053    $        --   $  (626)       $   (1,567)     $(2,193)  $ 60,924   $410,784 
--------------   -------       --------    ------           -------       ------    -------    ------- 
 
Balance, 
 December 31, 
 2025            363,246             --       136              (359)        (223)    58,546    421,569 
 
Profit                --             --        --                --           --     29,420     29,420 
Other 
 comprehensive 
 loss                 --             --      (421)           (2,147)      (2,568)        --     (2,568) 
--------------   -------       --------    ------           -------       ------    -------    ------- 
Total 
 comprehensive 
 income 
 (loss)               --             --      (421)           (2,147)      (2,568)    29,420     26,852 
 
Share options 
 exercised        12,533         (3,075)       --                --           --         --      9,458 
Restricted 
 share units 
 vested           21,906         (3,902)       --                --           --    (18,004)        -- 
Performance 
 share units 
 vested            7,934             --        --                --           --     (7,934)        -- 
Share-based 
 payments             --          6,977        --                --           --         --      6,977 
Shares 
 repurchased      (8,333)            --        --                --           --    (53,825)   (62,158) 
Change in 
 obligation 
 for share 
 repurchases     (10,506)            --        --                --           --         --    (10,506) 
--------------   -------       --------    ------  ---      -------       ------    -------    ------- 
Total 
 shareholder 
 transactions     23,534             --        --                --           --    (79,763)   (56,229) 
 
Balance, March 
 31, 2026       $386,780    $        --   $  (285)       $   (2,506)     $(2,791)  $  8,203   $392,192 
--------------   -------       --------    ------           -------       ------    -------    ------- 
 
 
 
Kinaxis Inc. 
 Condensed Consolidated Interim Statements of Cash Flows 
 (Expressed in thousands of USD) 
 
                                          Three months ended March 31, 
                                                 2026              2025 
------------------------------------      -----------       ----------- 
 
Cash flows from operating activities 
 
  Profit                               $       29,420      $     15,913 
  Items not affecting cash: 
      Depreciation of property and 
       equipment and right-of-use 
       assets                                   3,837             4,619 
      Amortization of intangible 
       assets                                     839               804 
      Share-based payments                      8,620             9,347 
      Net finance income                       (2,534)           (2,366) 
      Income tax expense                       13,915             5,740 
  Change in operating assets and 
   liabilities                                  6,829            13,781 
  Interest received                             2,565             2,903 
  Interest paid                                  (422)             (449) 
  Income taxes paid                            (3,987)          (18,645) 
------------------------------------      -----------       ----------- 
                                               59,082            31,647 
Cash flows from (used in) investing 
activities 
 
  Purchase of property and equipment             (990)           (1,582) 
  Purchase of short-term investments          (25,700)         (122,445) 
  Redemption of short-term 
   investments                                103,577            77,564 
------------------------------------      -----------       ----------- 
                                               76,887           (46,463) 
Cash flows used in financing 
activities 
 
  Payment of lease obligations                 (1,500)           (1,561) 
  Repurchase of shares                        (61,592)          (17,388) 
  Proceeds from exercise of stock 
   options                                      9,458             5,820 
------------------------------------      -----------       ----------- 
                                              (53,634)          (13,129) 
 
Increase (decrease) in cash and cash 
 equivalents                                   82,335           (27,945) 
 
Cash and cash equivalents, beginning 
 of period                                    149,614           172,192 
 
Effects of exchange rates on cash 
 and cash equivalents                          (1,820)             (758) 
------------------------------------      -----------       ----------- 
Cash and cash equivalents, end of 
 period                                $      230,129      $    143,489 
------------------------------------      -----------       ----------- 
 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260506915169/en/

 
    CONTACT:    Investor Relations 

Rick Wadsworth | Kinaxis

rwadsworth@kinaxis.com

613-907-7613

Media Relations

Matt Tatham | Kinaxis

mtatham@kinaxis.com

917-446-7227

 
 

(END) Dow Jones Newswires

May 06, 2026 17:00 ET (21:00 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10